Skip to main content
Fig. 3 | Orphanet Journal of Rare Diseases

Fig. 3

From: Long-term outcomes after allogeneic hematopoietic stem cell transplantation for metachromatic leukodystrophy: the largest single-institution cohort report

Fig. 3

Age to entry into GMFC-MLD levels for LI-MLD and J-MLD patients in the HSCT cohort. Numbers preceding each line refer to the Patient ID (see Tables 1 and 2). Circles represent time at entry into a respective level. Each line ends at most recent follow-up. Some patients had evaluable gross motor function data prior to HSCT. See Fig. 1 for GMFC-MLD level definitions. Patients were labeled symptomatic at the time of HSCT if they exhibited any clinical manifestation of MLD

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172